Ebg Medaustron Gmbh
Clinical trials sponsored by Ebg Medaustron Gmbh, explained in plain language.
-
New combo therapy aims to shrink pancreatic tumors before surgery
Disease control Recruiting nowThis study tests a treatment plan for people with borderline resectable pancreatic cancer. Participants first receive chemotherapy, then proton radiation combined with more chemo, followed by surgery if possible. The goal is to see if this approach is safe and helps control the d…
Phase: NA • Sponsor: EBG MedAustron GmbH • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
New radiation approach aims to control pancreatic tumors
Disease control Recruiting nowThis study tests a high-dose, short-course radiation treatment for people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this approach can control tumor growth in the treated area for at least two years. About 30 participants will…
Phase: NA • Sponsor: EBG MedAustron GmbH • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New registry study to monitor ion beam therapy outcomes
Knowledge-focused Recruiting nowThis study is a registry that collects information from about 2,800 tumor patients treated with ion beam therapy at MedAustron. The goal is to track treatment response, survival, side effects, and quality of life over time. No new treatment is being tested; instead, researchers a…
Sponsor: EBG MedAustron GmbH • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC